- 0208 903 4819
- Weekday Hours: 10AM - 5PM
One of the most prevalent adverse effects of perimenopause and menopause, affecting at least 50%
of women, is weight gain. Research from the SWAN and Healthy Women’s studies indicates that
women gain roughly 1.5 kg annually throughout perimenopause, adding up to an average weight gain
of 10kg by the time they approach menopause.
One of the most prevalent adverse effects of perimenopause and menopause, affecting at least 50%
of women, is weight gain. Research from the SWAN and Healthy Women’s studies indicates that women gain roughly 1.5 kg annually throughout perimenopause, adding up to an average weight gain
of 10kg by the time they approach menopause.
Mounjaro can be useful in managing women with menopausal weight gain. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. A medical background check is required so that the patient is 100% safe to take the medication. The patient wouldvstart on the starter dose of 2.5mg if approved for Mounjaro.
Mounjaro can be useful in managing women with menopausal weight gain. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. A medical background check is required so that the patient is 100% safe to take the medication. The patient wouldvstart on the starter dose of 2.5mg if approved for Mounjaro.
Mounjaro works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by
increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Increasing insulin secretion: Mounjaro stimulates the release of insulin from the pancreas, which helps to
lower blood sugar levels.
Slowing gastric emptying: Mounjaro slows down the movement of food from the stomach into the small
intestine, which helps you feel full for longer and eat less.
Suppressing glucagon secretion: Mounjaro reduces the release of glucagon from the pancreas, which helps to
prevent the liver from releasing too much sugar into the bloodstream.
Mounjaro works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Increasing insulin secretion:
Mounjaro stimulates the release of insulin from the pancreas, which helps to lower blood sugar levels.
Slowing gastric emptying:
Mounjaro slows down the movement of food from the stomach into the small
intestine, which helps you feel full for longer and eat less.
Suppressing glucagon secretion:
Mounjaro reduces the release of glucagon from the pancreas, which helps to prevent the liver from releasing too much sugar into the bloodstream.
Mounjaro (tirzepatide), primarily approved for treating type 2 diabetes, has shown potential benefits for weight loss, which may appeal to menopausal women experiencing weight gain. Menopause can lead to weight gain due to hormonal changes, decreased metabolism, and increased insulin resistance, all of which contribute to the accumulation of abdominal fat. Although there is no specific research on Mounjaro’s effects exclusively in menopausal women, its effectiveness in promoting weight loss and improving blood sugar control is well documented.
Mounjaro (tirzepatide), primarily approved for treating type 2 diabetes, has shown potential benefits for weight loss, which may appeal to menopausal women experiencing weight gain. Menopause can lead to weight gain due to hormonal changes, decreased metabolism, and increased insulin resistance, all of which contribute to the accumulation of abdominal fat. Although there is no specific research on Mounjaro’s effects exclusively in menopausal women, its effectiveness in promoting weight loss and improving blood sugar control is well documented.
Before recommending Mounjaro for weight management, medical professionals will evaluate a number of aspects, including general health and BMI. If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Mounjaro. There maybe a few factors preventing the prescribing of Mounjaro such as Thyroid cancer or any medical conditions which could be a health risk.
Before recommending Mounjaro for weight management, medical professionals will evaluate a number of aspects, including general health and BMI. If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Mounjaro. There maybe a few factors preventing the prescribing of Mounjaro such as Thyroid cancer or any medical conditions which could be a health risk.
Read our articles on Mounjaro and Wegovy if you would like to learn more about the benefits, the research and case studies.
Videos created by our chief doctor on managing and understanding Mounjaro to help you achieve the best outcomes possible.
Book an Appointment Today
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic
